Overview


According to FutureWise analysis the Immune Repertoire Sequencing Market in 2025 is US$ 360 million, and is expected to reach US$ 648.7 million by 2033 at a CAGR of 7.65%. This market is expanding due to rising applications in cancer immunotherapy, autoimmune disease research, and vaccine development. Immune repertoire sequencing offers detailed profiling of B-cell and T-cell receptors, providing key insights into immune responses and supporting precision medicine efforts.

The immune repertoire is defined as the sum of T cell receptors and B cell receptors (also known as immunoglobulin) that comprise the adaptive immune system of an organism. B-cell receptor (BCR) and T-cell receptor (TCR) receptors on the surface of B and T cells, respectively, mediate human adaptive immune system protection. Next-generation sequencing (NGS) advancements have enabled the development of immune repertoire sequencing, a powerful new technology for probing the complementary determining region of these receptors. Immune repertoire sequencing has aided in the profiling of antigen-specific information within lymphocytes and has grown in importance in understanding the body's auto-defence mechanisms against foreign agents.

Animals that reproduce and are more suited to their environments are favoured by natural selection. During an immune response, only lymphocytes that have the proper receptor to bind to an antigen in the immune repertoire will be activated and multiply, creating a clone of cells with identical antigen receptors. Understanding the immune repertoire is essential in the development of targeted therapy and immunotherapy, where treatments are being developed that are customised to an individual for improved success. Many medications that affect the immune system are either being researched or are already in use. Assessing the immune repertoire may help with therapy result prediction and side effect monitoring. The use of cytokines as medicines is one example of a treatment that broadens the immune repertoire.

Single-Cell Sequencing: Facilitates detailed analysis of individual immune cells, offering insights into immune responses at a detailed level.

Long-Read Sequencing: The process allows for detailed profiling of T-cell and B-cell receptors, enhancing our understanding of immune diversity.

FutureWise Market Research has published a report that provides an insightful analysis of immune repertoire sequencing market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

  • ABVITRO (NOW JUNO THERAPEUTICS)
  • ADAPTIVE BIOTECHNOLOGIES
  • AGILENT TECHNOLOGIES
  • ARCHERDX, INC
  • BGI
  • ILLUMINA, INC.
  • IREPERTOIRE, INC.
  • OXFORD NANOPORE TECHNOLOGIES, LTD
  • PACIFIC BIOSCIENCES
  • Qiagen N.V.
  • Takara Bio Inc.
  • CD Genomics
  • Roche Holding AG 
  • Thermo Fisher Scientific

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Immune Repertoire Sequencing Market:

ILLUMINA, INC.

  • Acquired Fluent BioSciences in July 2024, enhancing its capabilities in single-cell and multi-omics analytics, which are essential for immune repertoire profiling through TCR/BCR sequencing.
  • In October 2024, the compact and low-cost MiSeq i100 Plus sequencers were launched, expanding access to immune sequencing workflows for smaller institutions beyond large-scale research facilities.

Thermo Fisher Scientific, Inc. 

Thermo Fisher has been improving its product range to include advanced sequencing technologies and reagents, addressing the increasing demand for immune repertoire sequencing in both clinical and research applications.

By Product

  • Instrument
    • NGS
    • PCR
  • Assay, Kits And Reagent
    • TCR Kits
      • Human TCR Kits
      • Mouse TCR Kits
    • BCR Kits
      • Human BCR Kits
      • Mouse BCR Kits
  • Analytical Software
    • TCR Analysis Solutions
    • BCR Analysis Solutions
    • TCR And BCR Analysis Solutions
  • Services
    • Pre-Sequencing Services
    • Sequencing Services
    • Data Analysis Services

By Application

  • Biomarker Discovery
  • Autoimmune Diseases
  • Cancer Immunotherapy
  • Infectious Disease Research
  • Asthma and Allergy Research
  • Vaccine Development
  • Immunodeficiency Identification
  • Others (If Any)

By End User

  • Diagnostic Labs
  • Pharmaceutical and Biotech Companies
  • Research Institutes
  • Others (If Any)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Here’s a regional view of where the most progress is happening:

The North American region dominates the Immune Repertoire Sequencing (IRS) Market in terms of growth and market share. Key drivers include a strong healthcare infrastructure, significant investment in immunotherapy research, and the presence of leading biotech companies.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Immune Repertoire Sequencing Market By Product, By Application, By End-User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Immune Repertoire Sequencing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Immune Repertoire Sequencing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Immune Repertoire Sequencing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Immune Repertoire Sequencing Market, By Product Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Instrument
         1.1. NGS
         1.2. PCR
        2. Assay, Kits and Reagent
         2.1. TCR Kits
          2.1.1. Human TCR Kits
          2.1.2. Mouse TCR Kits
         2.2. BCR Kits
          2.2.1. Human BCR Kits
          2.2.2. Mouse BCR Kits
        3. Analytical Software
         3.1. TCR Analysis Solutions
         3.2. BCR Analysis Solutions
         3.3. TCR And BCR Analysis Solutions
        4. Services
         4.1. Pre-Sequencing Services
         4.2. Sequencing Services
         4.3. Data Analysis Services

  • 8.   Immune Repertoire Sequencing Market, By Application Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Biomarker Discovery
        2. Autoimmune Diseases
        3. Cancer Immunotherapy
        4. Infectious Disease Research
        5. Asthma and Allergy Research
        6. Vaccine Development
        7. Immunodeficiency Identification
        8. Others (If Any)

  • 9.   Immune Repertoire Sequencing Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Diagnostic Labs
        2. Pharmaceutical and Biotech Companies
        3. Research Institutes
        4. Others (If Any)

  • 10.   North America Immune Repertoire Sequencing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 11.   Latin America Immune Repertoire Sequencing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 12.   Europe Immune Repertoire Sequencing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 13.   Asia Pacific Immune Repertoire Sequencing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 14.   Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. ABVITRO (NOW JUNO THERAPEUTICS)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. ADAPTIVE BIOTECHNOLOGIES
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AGILENT TECHNOLOGIES
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. ARCHERDX, INC.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BGI
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. ILLUMINA, INC.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. IREPERTOIRE, INC.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. OXFORD NANOPORE TECHNOLOGIES, LTD
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. PACIFIC BIOSCIENCES
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Qiagen N.V.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Takara Bio Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. CD Genomics
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Roche Holding AG
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Thermo Fisher Scientific
                 14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

FAQ


Immune Repertoire Sequencing is pivotal in research areas such as vaccine development, cancer immunotherapy, autoimmunity studies, and infectious disease monitoring. In diagnostics, it is used to assess lymphoid malignancies, track patient responses to immunotherapies, and identify potential biomarkers for various diseases.

While general sequencing methods capture the broad genomic information, IR-seq specifically targets the unique regions of the immune cells’ receptors. This focus allows for a deeper understanding of the immune system's capacity to recognize and fight off diverse pathogens and diseased cells.

The scope of this market is vast and growing, owing to increasing applications in personalized medicine. Though market sizes vary by analysis, there is a trend of substantial growth impacting healthcare through improved diagnostics and treatments with direct benefits for patient outcome and care.

Yes, our market forecast provides not only future projections but also historical data that gives context to the growth and evolution of the Immune Repertoire Sequencing Market. This data typically includes information on sales, therapeutic advancements, and market share distribution among key players.

Some of the latest trends include:
High-Throughput Sequencing: Rapid advances in technology allow processing of large sample volumes with deeper insights.
AI Integration: Artificial intelligence is being harnessed to interpret complex data.
Multiplexing Solutions: Platforms are being developed that can assess multiple immune parameters simultaneously.

Related Market

Immune Cell Engineering Market

Read More

Immune Health Supplements Market

Read More

Immune Globulin Intravenous Market

Read More

Immune Checkpoint Inhibitors Market

Read More
Partner

Our Clients